Latest Competition News

Page 159 of 374
Microba Life Sciences reported a 30% increase in revenue to $15.7 million for FY25, driven by strong growth in its core microbiome diagnostic products and successful UK market expansion. Despite narrowing its net loss to $14.9 million, the company is focused on scaling diagnostics adoption and achieving break-even in FY26.
Ada Torres
Ada Torres
26 Aug 2025
Hazer Group has reported a remarkable FY25 performance with revenues more than doubling and losses slashed by 60%, underpinned by a strategic partnership with KBR and early commercial revenues.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Hazer Group Limited reported a 124% surge in revenues to $8.5 million for FY25, driven by government grants, while cutting its net loss by 60%. The company advanced its proprietary methane pyrolysis technology, secured a strategic alliance with KBR, and made progress on key projects in Canada and Japan.
Maxwell Dee
Maxwell Dee
26 Aug 2025
WAM Active Limited reported a robust 26.4% increase in its investment portfolio for FY2025, significantly outperforming key benchmarks, while maintaining its fully franked dividend at 6.0 cents per share.
Victor Sage
Victor Sage
26 Aug 2025
Starpharma reports a significant 183% jump in FY25 revenue to $4.9 million, alongside a 31% reduction in losses and a solid cash position of $15.4 million. The biotech firm’s progress underscores growing momentum in its dendrimer technology pipeline.
Ada Torres
Ada Torres
26 Aug 2025
Kip McGrath Education Centres Ltd reported solid FY25 financial results with revenue and profit growth driven by franchise expansion and premium tutoring offerings. The company anticipates continued revenue growth and improved profitability in FY26 despite flat lesson volumes.
Victor Sage
Victor Sage
26 Aug 2025
Evergreen Lithium has secured rights to two promising gold projects in Western Australia’s premier goldfields, significantly boosting its exploration footprint with minimal upfront cash outlay. The acquisitions position the company to leverage historical data and regional infrastructure as it advances toward becoming a gold producer.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Scentre Group reported a 3.2% rise in Funds From Operations for H1 2025 and upgraded its full-year distribution guidance, driven by record occupancy and retail sales growth across its Westfield portfolio.
Eva Park
Eva Park
26 Aug 2025
Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.
Ada Torres
Ada Torres
26 Aug 2025
Integral Diagnostics (IDX) reported a robust FY25 with 33.7% revenue growth and operating EBITDA margin expansion, driven by the Capitol merger and organic growth. The company exceeded synergy expectations and outlined a confident outlook amid favourable industry tailwinds.
Ada Torres
Ada Torres
26 Aug 2025
Integrated Research Limited reported an 18% revenue decline and a 51% drop in net profit for FY25, while unveiling a strategic pivot towards AI-driven product innovation and cloud services.
Sophie Babbage
Sophie Babbage
26 Aug 2025
Carindale Property Trust reported a solid 6.4% increase in revenue to $61.6 million and a significant jump in net profit to $39.2 million for the year ended 30 June 2025, underpinned by strong property valuations and operational performance.
Eva Park
Eva Park
26 Aug 2025